Trade unions & drug firms in no-deal Brexit preparations ink 26 NDAs
Date: 2018-12-24   Author: Pankaj Singh  Category: #news

Trade unions & drug firms in no-deal Brexit preparations ink 26 NDAs

Reports suggest that pharmaceutical firms that are working with Whitehall for maintaining medicine supplies in case of a no-deal Brexit event have signed 26 suppressive orders. Apparently, these orders are aimed at barring the pharmaceutical firms from revealing information to the public.

According to figures released, 10 trade associations and 16 drug companies have allegedly been asked to ink non-disclosure agreements (NDAs) that would bar them from disclosing any information regarding contingency plans, which are drawn up with the Department of Health and Social Care.

This further means the government has asked a minimum of 60 partners that are seemingly working towards preparing for a no-deal Brexit across Whitehall to sign such agreements, much to the charging of MPs as well as transparency campaigners.

Health minister Stephen Hammond confirmed the reports, saying that the department has inked 10 NDAs with trade associations and 16 with private companies, since July 2016, with trade associations relating to its medical supply no-deal Brexit contingency planning.

These figures were recently released after a parliamentary question Rushanara Ali, a Labour party MP. Ali, a MP for Bethnal Green and Bow, stated that the public’s right to know about any threats to public health are disregarded with a number of agreements being used to silence the companies.

Ali was quoted saying that the use of NDAs by the government, with the trade associations and pharmaceutical businesses, is utterly unacceptable. These secretive agreements are preventing vital information from being shared, by effectively gagging these companies, hampering the ability of businesses to speak out and undermining transparency.

Citing sources familiar with the matter, Whitehall has become so secretive that crucial information is only being provided to a few companies orally, or through hard copies of documents which are to be returned at the end of any meeting.

The pharmaceutical industry, which has been in close contact with the government, is stockpiling drugs for ensuring access to vital medicines in an event of disrupted supply routes by delays at the border, sources further mentioned.



About Author


Pankaj Singh

Pankaj Singh

Pankaj Singh Develops content for Algosonline, Market Size Forecasters, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More from Pankaj


Post Recommendents

Freshworks looks for a fresh funding round to aim at $3 Bn valuation
Author: Saipriya Iyer

As per NASSCOM, India’s software as a service (SaaS) industry is slated to grow 36 percent annually and reach $3.3-$3.4 billion by 2022. Cheaper workforce, mature sales ecosystem, abundant talent and adoption of ...


CARFIT finishes seed funding round with PlugandPlay and CIC Capital
Author: Paroma Bhattacharya

Global predictive maintenance sector is predicted to witness an exponential growth over the coming years. Seeing the immense growth opportunity, several global venture capital firms are increasingly investing in predic...


Diamond uses Zuora® Central platform to launch digital media services
Author: Pankaj Singh

Digital media has tremendously grown its presence in recent years. Looking at its potential, several media companies have decided to come out with their own digital media subscription services. One such initiative...